Vaccinex Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.00
Dividend & YieldN/A$ (N/A)
Beta 1.29
Market capitalization 19.44M
Operating cash flow -19.62M
ESG Scores unknown

Company description

Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D (SEMA4D). The company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. It has also developed a proprietary drug discovery platform, ActivMAb that it is leveraging through strategic collaborations, by exploiting its unique capability to select antibodies against multi-pass membrane receptors. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.

Sector: Healthcare - Industry: Biotechnology

Financial Ratios
Quick Ratio4.17
Working Capital-3.13
Return On Equity-3.02
Debt To Equity0.02
Fixed Asset Ratio5.77
Fixed Interest Cover-27.8

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 123k 725k 122k -2.11M
Total Cashflows From Investing Activities -14.24M 14.07M -290k -32k
Net Borrowings -5.5M 9.03M 9.03M -8.54M
Total Cash From Financing Activities 40.95M 13.8M 36.76M 23.32M
Change To Operating Activities 2.02M 31k -1.93M -1.26M
Issuance Of Stock 37.13M 13.8M 28.49M 32.85M
Net Income -29.52M -31.86M -28.85M -22.38M
Change In Cash 1.44M -2.84M 7.82M -2.01M
Effect Of Exchange Rate
Total Cash From Operating Activities -25.28M -30.71M -28.65M -25.3M
Depreciation 223k 249k 307k 169k
Change To Account Receivables -522k -260k 741k 157k
Other Cashflows From Financing Activities 9.32M -763k -763k -985k
Change To Netincome 2.09M 403k 964k 123k
Capital Expenditures -235k -78k -290k -32k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 22.35M
Income Before Tax -29.52M -31.86M -28.85M -22.38M
Net Income -29.52M -31.86M -28.85M -22.38M
Selling General Administrative 4.62M 6.67M 7.41M 6.23M
Gross Profit -309k -25.35M -20.93M -16.26M
Ebit -27.28M -32.02M -28.33M -22.49M
Operating Income -27.28M -32.02M -28.33M -22.49M
Interest Expense -392k -489k -489k -809k
Income Tax Expense
Total Revenue 724k 523k 625k 900k
Cost Of Revenue 1.03M 25.87M 21.55M 17.16M
Total Other Income ExpenseNet -2.24M 152k -520k 110k
Net Income From Continuing Ops -29.52M -31.86M -28.85M -22.38M
Net Income Applicable To Common Shares -29.52M -31.86M -28.85M -22.38M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 6.69M 6.88M 14.31M 2.43M
Total Stockholder Equity -8.62M -26.24M -26.57M 7.41M
Other Current Liabilities
Total Assets 22.03M 4.6M 11.7M 9.84M
Common Stock 1k 1k 3k 3k
Other Current Assets
Retained Earnings -216.77M -248.63M -277.48M -299.86M
Treasury Stock -11k -11k -11k -11k
Cash 5.62M 2.78M 10.6M 8.59M
Total Current Liabilities 6.69M 6.88M 13.18M 2.26M
Other Stockholder Equity
Property, Plant, and Equipment 604k 594k 416k 438k
Total Current Assets 21.42M 4.01M 11.29M 9.4M
Net Tangible Assets -8.62M -26.24M -26.57M 7.41M
Net Receivables 639k 898k 157k
Accounts Payable 2.32M 3.21M 3.17M 1.06M


Insider Transactions

Here are the insider transactions of stock shares related to Vaccinex Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
VAN STRYDONCK GERALD EPurchase at price 1.30 - 1.32 per share.D2022-02-23Director20k
FRIEDBERG ALBERT DPurchase at price 0.92 per share.I2022-01-27Director and Beneficial Owner of more than 10% of a Class of Security3.6M
ZAUDERER MAURICEPurchase at price 0.92 per share.I2022-01-27Chief Executive Officer1.8M
FRIEBERG JACOB BPurchase at price 0.92 per share.I2022-01-27Director90.09k
FRIEBERG JACOB BD/I2021-06-25Director12.96k
FRIEDBERG ALBERT DI2021-05-24Director and Beneficial Owner of more than 10% of a Class of Security2.15M

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Vaccinex Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Vaccinex Inc

Here is the result of two systematic investment strategies applied to Vaccinex Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Vaccinex Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Vaccinex Inc:

Vaccinex Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -33.46% on the backtest period.

Performance at glance

Performance

-33.46 %

Latent gain

-502.33 $

Invested capital

1501.33 $

Annualized return

-10.2 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Vaccinex Inc

This is the result of two momentum investment strategies applied to Vaccinex Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Vaccinex Inc

The following chart shows all the entries opened by the momentum investment system on Vaccinex Inc:

Vaccinex Inc momentum entries
  • The first momentum investment strategy would give -31.22% of return on Vaccinex Inc. That represents -1404.38$ of latent gain with 4498.13$ of employed capital.
  • The second momentum investment strategy would give -36.4% of return on Vaccinex Inc. That represents -820.2$ of latent gain with 2253.45$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-31.22 %

Latent gain

-1404.38 $

Invested capital

4498.13 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

-36.4 %

Latent gain

-820.2 $

Invested capital

2253.45 $

Annualized return

-13.0 %

Momentum equity curve on Vaccinex Inc

The following chart shows the equity curve of the two momentum strategies applied to Vaccinex Inc:

Vaccinex Inc momentum equity

Note: the dividends potentially given by Vaccinex Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Vaccinex Inc

The following chart shows the employed capital evolution of the two momentum strategies on Vaccinex Inc since the beginning:

Vaccinex Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Vaccinex Inc

Buy the dip entry openings on Vaccinex Inc

Vaccinex Inc

The performance achieved by the robo-advisor on Vaccinex Inc is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Vaccinex Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Vaccinex Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to Vaccinex Inc

The following chart shows the result of the investment strategy applied to Vaccinex Inc:

Vaccinex Inc

Note: the dividends potentially given by Vaccinex Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Vaccinex Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Vaccinex Inc:

Vaccinex Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Vaccinex Inc

In this section, I will compare the three previous investment strategies applied to Vaccinex Inc.

Equity curve comparison on Vaccinex Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Vaccinex Inc investment strategy comparison

Employed capital comparison on Vaccinex Inc

Vaccinex Inc investment comparison

Performance comparison on Vaccinex Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -33.46% -502.33$ 1501.33$ -10.2%
Momentum 1 quarter -31.22% -1404.38$ 4498.13$ -10.27%
Momentum 2 quarters -36.4% -820.2$ 2253.45$ -13.0%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

-10.2 %

Momentum 1Q

-13.0 %

Momentum 2Q

-13.0 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Vaccinex Inc:

Positive correlations

Most correlated stocks this year

  • Vaccinex Inc

  • Most correlated stocks last 3 months

  • S.A.S. DRAGON
  • Vaccinex Inc
  • LANGHAM-SS
  • CHAMPION REIT
  • AMARA
  • COASTAL GL
  • RONSHINECHINA
  • SH ELECTRIC
  • EMPEROR CAPITAL

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between Vaccinex Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Vaccinex Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Vaccinex Inc
    Country United States
    City Rochester
    Address 1895 Mount Hope Avenue
    Phone 585 271 2700
    Website www.vaccinex.com
    FullTime employees 39
    Industry Biotechnology
    Sector Healthcare
    Exchange XNAS
    Ticker VCNX
    Market www.nasdaq.com

    Vaccinex Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown